FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1995685370> ?p ?o ?g. }

• W1995685370 endingPage "453" @default.
• W1995685370 startingPage "444" @default.
• W1995685370 abstract "Aim To explore the rate of add-on therapy with solifenacin in men with voiding and storage lower urinary tract symptoms (LUTS) after tamsulosin monotherapy and to explore predictive factors for starting solifenacin add-on therapy. Methods Men aged ≥ 45 years with IPSS ≥ 12 and symptoms of OAB (OAB-V8 ≥ 8, micturition ≥ 8/24 h, urgency ≥ 2/24 h) were enrolled to receive tamsulosin 0.2 mg once daily. After 4 weeks, men with residual symptoms of OAB and reported ‘dissatisfied’ or ‘a little satisfied’ were received solifenacin 5 mg in combination with tamsulosin monotherapy. Subjects completed an IPSS, a Quality of life (QoL) index, OAB V8, and an International Consultation of Incontinence Questionnaire (ICIQ)-Male LUTS, and patient perception of bladder condition (PPBC) at baseline and week 4. Results Of a total of 305 patients, 254 patients completed 4 weeks of tamsulosin treatment. For 176 patients, solifenacin was added (69.3%). Significant predictive factors of solifenacin add-on therapy included long LUTS duration, high IPSS, number of micturitions per 24 h, more urgency episodes, high urgency severity score in a voiding diary and high OAB V8 score. Based on multivariable analysis, potential predictive factors of solifenacin add-on therapy included long LUTS duration (OR = 1.008, 95% CI: 1.001–1.014), high serum PSA (OR = 1.543, 95% CI: 1.136–2.095) and small prostate size (OR = 0.970, 95% CI: 0.947–0.994) (p < 0.05). IPSS, daytime micturitions and urgency episodes, OAB V8 scores, ICIQ and PPBC were improved after tamsulosin monotherapy. Conclusions Two thirds of men with voiding and storage LUTS needed to add anticholinergics after 4 weeks of tamsulosin monotherapy. Patients with longer lasting symptoms and storage symptoms with small prostate volume may require the anticholinergic add-on." @default.
• W1995685370 created "2016-06-24" @default.
• W1995685370 creator A5002893369 @default.
• W1995685370 creator A5004432186 @default.
• W1995685370 creator A5006276321 @default.
• W1995685370 creator A5019918659 @default.
• W1995685370 creator A5020020944 @default.
• W1995685370 creator A5041983088 @default.
• W1995685370 creator A5052608071 @default.
• W1995685370 creator A5053605865 @default.
• W1995685370 creator A5058689509 @default.
• W1995685370 creator A5070183938 @default.
• W1995685370 date "2014-11-01" @default.
• W1995685370 modified "2023-09-27" @default.
• W1995685370 title "Rate and associated factors of solifenacin add-on after tamsulosin monotherapy in men with voiding and storage lower urinary tract symptoms" @default.
• W1995685370 cites W1557253144 @default.
• W1995685370 cites W1970542756 @default.
• W1995685370 cites W1979747755 @default.
• W1995685370 cites W1983094092 @default.
• W1995685370 cites W1987249698 @default.
• W1995685370 cites W1987967806 @default.
• W1995685370 cites W1992243709 @default.
• W1995685370 cites W2004556039 @default.
• W1995685370 cites W2006100624 @default.
• W1995685370 cites W2009244027 @default.
• W1995685370 cites W2011746657 @default.
• W1995685370 cites W2018142772 @default.
• W1995685370 cites W2022422644 @default.
• W1995685370 cites W2022805390 @default.
• W1995685370 cites W2034265241 @default.
• W1995685370 cites W2053816709 @default.
• W1995685370 cites W2060253131 @default.
• W1995685370 cites W2061757654 @default.
• W1995685370 cites W2064005865 @default.
• W1995685370 cites W2064203330 @default.
• W1995685370 cites W2078997630 @default.
• W1995685370 cites W2079938318 @default.
• W1995685370 cites W2103581840 @default.
• W1995685370 cites W2132044709 @default.
• W1995685370 cites W2134121470 @default.
• W1995685370 cites W2170365273 @default.
• W1995685370 cites W2341507669 @default.
• W1995685370 cites W4247964941 @default.
• W1995685370 cites W4254178313 @default.
• W1995685370 doi "https://doi.org/10.1111/ijcp.12581" @default.
• W1995685370 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25363606" @default.
• W1995685370 hasPublicationYear "2014" @default.
• W1995685370 type Work @default.
• W1995685370 sameAs 1995685370 @default.
• W1995685370 citedByCount "14" @default.
• W1995685370 countsByYear W19956853702015 @default.
• W1995685370 countsByYear W19956853702016 @default.
• W1995685370 countsByYear W19956853702017 @default.
• W1995685370 countsByYear W19956853702018 @default.
• W1995685370 countsByYear W19956853702019 @default.
• W1995685370 countsByYear W19956853702020 @default.
• W1995685370 countsByYear W19956853702021 @default.
• W1995685370 countsByYear W19956853702022 @default.
• W1995685370 countsByYear W19956853702023 @default.
• W1995685370 crossrefType "journal-article" @default.
• W1995685370 hasAuthorship W1995685370A5002893369 @default.
• W1995685370 hasAuthorship W1995685370A5004432186 @default.
• W1995685370 hasAuthorship W1995685370A5006276321 @default.
• W1995685370 hasAuthorship W1995685370A5019918659 @default.
• W1995685370 hasAuthorship W1995685370A5020020944 @default.
• W1995685370 hasAuthorship W1995685370A5041983088 @default.
• W1995685370 hasAuthorship W1995685370A5052608071 @default.
• W1995685370 hasAuthorship W1995685370A5053605865 @default.
• W1995685370 hasAuthorship W1995685370A5058689509 @default.
• W1995685370 hasAuthorship W1995685370A5070183938 @default.
• W1995685370 hasBestOaLocation W19956853701 @default.
• W1995685370 hasConcept C121608353 @default.
• W1995685370 hasConcept C126322002 @default.
• W1995685370 hasConcept C126894567 @default.
• W1995685370 hasConcept C142724271 @default.
• W1995685370 hasConcept C159110408 @default.
• W1995685370 hasConcept C175768497 @default.
• W1995685370 hasConcept C204787440 @default.
• W1995685370 hasConcept C2776235491 @default.
• W1995685370 hasConcept C2776547966 @default.
• W1995685370 hasConcept C2777562237 @default.
• W1995685370 hasConcept C2778531004 @default.
• W1995685370 hasConcept C2778941218 @default.
• W1995685370 hasConcept C2779478474 @default.
• W1995685370 hasConcept C2779502394 @default.
• W1995685370 hasConcept C2779951463 @default.
• W1995685370 hasConcept C2780542891 @default.
• W1995685370 hasConcept C71924100 @default.
• W1995685370 hasConcept C77411442 @default.
• W1995685370 hasConceptScore W1995685370C121608353 @default.
• W1995685370 hasConceptScore W1995685370C126322002 @default.
• W1995685370 hasConceptScore W1995685370C126894567 @default.
• W1995685370 hasConceptScore W1995685370C142724271 @default.
• W1995685370 hasConceptScore W1995685370C159110408 @default.
• W1995685370 hasConceptScore W1995685370C175768497 @default.
• W1995685370 hasConceptScore W1995685370C204787440 @default.
• W1995685370 hasConceptScore W1995685370C2776235491 @default.
• W1995685370 hasConceptScore W1995685370C2776547966 @default.

• next